Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D1AL
|
|||
Former ID |
DAP000313
|
|||
Drug Name |
Haloperidol
|
|||
Synonyms |
Aldo; Aloperidin; Aloperidol; Aloperidolo; Aloperidon; Bioperidolo; Brotopon; Dozic; Dozix; Eukystol; Fortunan; Galoperidol; Haldol; Halidol; Halojust; Halol; Halopal; Haloperido; Haloperidolum; Halopidol; Halopoidol; Halosten; Keselan; Linton; Mixidol; Pekuces; Peluces; Peridol; Pernox; Serenace; Serenase; Serenelfi; Sernas; Sernel; Sigaperidol; Ulcolind; Uliolind; Vesalium; Aloperidolo [DCIT]; Aloperidolo [Italian]; Einalon S; Haldol La; Haldol Solutab; Lealgin compositum; Pms Haloperidol; H 1512; R 1625; Aloperidin (TN); Apo-Haloperidol; Bioperidolo (TN); Brotopon (TN); Dozic (TN); Duraperidol (TN); Einalon S (TN); Eukystol (TN); Haldol (TN); Haloperidolum [INN-Latin]; Halosten (TN); Keselan (TN); Linton (TN);Novo-Peridol; Peluces (TN); R-1625; Serenace (TN); Serenase (TN); Sigaperidol (TN); Haloperidol (JP15/USP); McN-JR-1625; Haloperidol (JP15/USP/INN); Haloperidol [USAN:INN:BAN:JAN]
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Schizophrenia [ICD-11: 6A20] | Approved | [1], [2] | |
Therapeutic Class |
Antipsychotic Agents
|
|||
Company |
Janssen Pharmaceutica
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H23ClFNO2
|
|||
Canonical SMILES |
C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
|
|||
InChI |
1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
|
|||
InChIKey |
LNEPOXFFQSENCJ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 52-86-8
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
4938, 443245, 487337, 597375, 855969, 5123760, 7847204, 7979526, 8149365, 8152250, 10321347, 10525411, 11111260, 11112116, 11113356, 11335829, 11361068, 11363755, 11364802, 11366317, 11367364, 11368879, 11369926, 11371416, 11372966, 11374119, 11375526, 11377041, 11378093, 11462040, 11466143, 11467263, 11484972, 11485805, 11489084, 11490264, 11492385, 11494675, 12013409, 14902191, 17405145, 24277917, 26611764, 26680483, 26747061, 26747062, 26751574, 26751575, 26758862, 29222690
|
|||
ChEBI ID |
CHEBI:5613
|
|||
ADReCS Drug ID | BADD_D01054 ; BADD_D01056 | |||
SuperDrug ATC ID |
N05AD01
|
|||
SuperDrug CAS ID |
cas=000052868
|
Interaction between the Drug and Microbe | Top | |||
---|---|---|---|---|
The Abundace of Studied Microbe(s) Regulated by Drug | ||||
The Order in the Taxonomic Hierarchy of the following Microbe(s): Eggerthellales | ||||
Studied Microbe: Eggerthella lenta
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Abundance Change | Decrease | |||
Experiment Method | High-throughput screening | |||
Description | The abundance of Eggerthella lenta was decreased by Haloperidol (adjusted p-values: 7.21E-03). | |||
The Order in the Taxonomic Hierarchy of the following Microbe(s): Verrucomicrobiales | ||||
Studied Microbe: Akkermansia muciniphila
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Abundance Change | Decrease | |||
Experiment Method | High-throughput screening | |||
Description | The abundance of Akkermansia muciniphila was decreased by Haloperidol (adjusted p-values: 6.62E-03). |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 86). | |||
REF 2 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
REF 3 | Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018 Mar 29;555(7698):623-628. | |||
REF 4 | Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment. Synapse. 2002 Aug;45(2):78-85. | |||
REF 5 | Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27-38. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.